Publikationen: Stefaan Van Gool MD. PhD. Archive - IOZK

Beiträge

Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors

2021-07-04/in International Publications /von 2021-07-04 / Cancer Immunol Immunother 2021 Jul;

Impaired DNA repair in mouse monocytes compared to macrophages and precursors

2020-12-30/in International Publications /von 2020-12-30 / DNA Repair (Amst) 2020 Dec;98:103037

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

2020-12-24/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, Newcastle Disease Virus /von 2020-12-24 / Cancers (Basel) 2020 Dec;13(1)

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit

2020-07-23/in Dendritic Cells, Hyperthermia, International Publications, Newcastle Disease Virus /von 2020-07-23 / Biomedicines 2020 Jul;8(8)

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

2020-06-30/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, Newcastle Disease Virus /von 2020-06-30 / Expert Rev Anticancer Ther 2020 Aug;20(8):639-646

Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience

2020-05-19/in Brain Tumors in Children, Dendritic Cells, Hyperthermia, International Publications, Newcastle Disease Virus /von 2020-05-19 / Medicines (Basel) 2020 May;7(5)

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

2020-03-01/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2020-03-01 / J Immunother Cancer 2020 Mar;8(1)

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy

2019-08-30/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Newcastle Disease Virus /von 2019-08-30 / Biomedicines 2019 Aug;7(3)

Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy

2019-04-01/in Dendritic Cells, Glioblastoma, International Publications /von 2019-04-01 / Anticancer Res. 2019 Apr;39(4):2043-2051

Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group

2016-07-12/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2016-07-12 / Cytotherapy 2016 09;18(9):1178-86